Search by Drug Name or NDC
NDC 51862-0096-01 DISOPYRAMIDE PHOSPHATE 150 mg/1 Details
DISOPYRAMIDE PHOSPHATE 150 mg/1
DISOPYRAMIDE PHOSPHATE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mayne Pharma Commercial LLC. The primary component is DISOPYRAMIDE PHOSPHATE.
MedlinePlus Drug Summary
Disopyramide is used to treat certain types of irregular heartbeats). Disopyramide is in a class of medications called antiarrhythmic medications. It works by making your heart more resistant to abnormal activity.
Related Packages: 51862-0096-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Disopyramide
Product Information
| NDC | 51862-0096 |
|---|---|
| Product ID | 51862-096_ffd27bfc-4d28-74b5-e053-6394a90a24e1 |
| Associated GPIs | 35100010100110 |
| GCN Sequence Number | 000240 |
| GCN Sequence Number Description | disopyramide phosphate CAPSULE 150 MG ORAL |
| HIC3 | A2A |
| HIC3 Description | ANTIARRHYTHMICS |
| GCN | 01131 |
| HICL Sequence Number | 000077 |
| HICL Sequence Number Description | DISOPYRAMIDE PHOSPHATE |
| Brand/Generic | Generic |
| Proprietary Name | DISOPYRAMIDE PHOSPHATE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | DISOPYRAMIDE PHOSPHATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 150 |
| Active Ingredient Units | mg/1 |
| Substance Name | DISOPYRAMIDE PHOSPHATE |
| Labeler Name | Mayne Pharma Commercial LLC |
| Pharmaceutical Class | Antiarrhythmic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA070173 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51862-0096-01 (51862009601)
| NDC Package Code | 51862-096-01 |
|---|---|
| Billing NDC | 51862009601 |
| Package | 100 CAPSULE in 1 BOTTLE (51862-096-01) |
| Marketing Start Date | 2022-04-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.56288 |
| Pricing Unit | EA |
| Effective Date | 2022-11-23 |
| NDC Description | DISOPYRAMIDE 150 MG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2022-11-23 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis